Sweet's syndrome with hematologic disorders: A review and reappraisal

International Journal of Dermatology

Volumn 47, Issue 8, 2008, Pages 775-782

  Buck, Thomas ^a   González, Lenis M ^a   Lambert, W Clark ^a   Schwartz, Robert A ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIINFECTIVE AGENT; ANTIMETABOLITE; BORTEZOMIB; CARCINOEMBRYONIC ANTIGEN; CLOFAZIMINE; COLCHICINE; CORTICOSTEROID; CORTICOTROPIN; CYCLOSPORIN; CYTOTOXIC AGENT; ETRETIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMATINIB; INTERLEUKIN 6; INTERLEUKIN 8; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM IODIDE; PREDNISOLONE; RETINOIC ACID; STEROID; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ANAMNESIS; BEHCET DISEASE; BLOOD CELL COUNT; BLOOD CHEMISTRY; CARBON DIOXIDE LASER; CELL MIGRATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MECHANISM; ERYTHEMA; GENE MUTATION; HEMATOLOGIC DISEASE; HEMATOLOGIC MALIGNANCY; HIDRADENITIS; HUMAN; IMMUNOASSAY; IMMUNOPATHOLOGY; LABORATORY TEST; LASER SURGERY; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; PARAPROTEINEMIA; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; PYODERMA GANGRENOSUM; REVIEW; SECONDARY INFECTION; THORAX RADIOGRAPHY; TRISOMY 8; UNSPECIFIED SIDE EFFECT; URINALYSIS;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOPSY, NEEDLE; COMBINED MODALITY THERAPY; COMORBIDITY; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; LASER THERAPY; MALE; PRECANCEROUS CONDITIONS; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SWEET'S SYNDROME;

EID: 48249136676     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2008.03859.x     Document Type: Review

References (101)

1. Cohen PR, Kurzrock R. Sweet's syndrome revisited: A review of disease concepts. Int J Dermatol 2003; 42: 761-778.
2. Fett DL, Gibson LE, Su WPD. Sweet's syndrome: Systemic signs and symptoms and associated disorders. Mayo Clin Proc 1995; 70: 234-240.
3. Sweet R. An acute febrile neutrophilic dermatosis. Br J Dermatol 1964; 76: 349-356.
4. Schwartz RA. Skin Cancer: Recognition and Management. Oxford, United Kingdom: Blackwell, 2008: 295-297.
5. Paoluzi OA, Crispino P, Amantea A, et al. Diffuse febrile dermatosis in a patient with active ulcerative colitis under treatment with steroids and azathioprine: A case of Sweet's syndrome. Case report and review of literature. Dig Liver Dis 2004; 36: 361-366.
6. Gyorfy A, Kovacs T, Szegedi I, et al. Sweet syndrome associated with 13-cis-retinoic acid (isotretinoin) therapy. Med Pediatr Oncol 2003; 40: 135-136.
7. Burrall B. Sweet's syndrome (acute febrile neutrophilic dermatosis). Dermatol Online J 1999; 5: 8.
8. von den Driesch P. Sweet's syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol 1994; 31: 535-556.
9. Satra D, Zalka A, Cohen P. Sweet's syndrome and pregnancy. J Am Acad Dermatol 1994; 30 (2pt2): 297-300.
10. Haliasos E, Soder B, Rubenstein DS, et al. Pediatric Sweet syndrome and immunodeficiency successfully treated with intravenous immunoglobulin. Pediatr Dermatol 2005; 22: 530-535.
11. Cohen PR, Kurzrock R. Sweet's syndrome and cancer. Clin Dermatol 1993; 11: 149-157.
12. Requena L, Kutzner H, Palmedo G, et al. Histiocytoid Sweet syndrome: A dermal infiltration of immature neutrophilic granulocytes. Arch Dermatol 2005; 141: 834-842.
13. Kawakami T, Ohashi S, Kawa Y, et al. Elevated serum granulocyte colony-stimulating factor levels in patients with active phase of sweet syndrome and patients with active Behcet disease: Implication in neutrophil apoptosis dysfunction. Arch Dermatol 2004; 140: 570-574.
14. Stucki A, Rivier AS, Gikic M, et al. Endothelial cell activation by myeloblasts: Molecular mechanisms of leukostasis and leukemic cell dissemination. Blood 2001; 97: 2121-2129.
15. Magro CM, De Moraes E, Burns F. Sweet's syndrome in the setting of CD34-positive acute myelogenous leukemia treated with granulocyte colony stimulating factor: Evidence for a clonal neutrophilic dermatosis. J Cutan Pathol 2001; 28: 90-96.
16. Watari K, Tojo A, Nagamura-Inoue T, et al. Hyperfunction of neutrophils in a patient with BCR/ABL negative chronic myeloid leukemia: A case report with in vitro studies. Cancer 2000; 89: 551-560.
17. Schneider DT, Schuppe HC, Schwamborn D, et al. Acute febrile neutrophilic dermatosis (Sweet syndrome) as initial presentation in a child with acute myelogenous leukemia. Med Pediatr Oncol 1998; 31: 178-181.
18. Nagao K, Kikuchi A, Kawai Y, et al. Skin infiltration in acute promyelocytic leukemia. Dermatology 1997; 194: 168-171.
19. Cohen PR, Kurzrock R. Sweet's syndrome: A review of current treatment options. Am J Clin Dermatol 2002; 3: 117-131.
20. Gunawardena DA, Gunawardena KA, Ratnayaka RM, et al. The clinical spectrum of Sweet's syndrome (acute febrile neutrophilic dermatosis): A report of eighteen cases. Br J Dermatol 1975; 92: 363-373.
21. Cohen PR, Talpaz M, Kurzrock R. Malignancy-associated Sweet's syndrome: review of the world literature. J Clin Oncol 1988; 6: 1887-1897.
22. Schwartz RA, French SW, Rubenstein DJ, et al. Acute neutrophilic dermatosis with diffuse histiocytic lymphoma. J Am Acad Dermatol 1984; 10: 350-354.
23. de las Casa C, Bueso-Ramos C, Esey E. The MD Anderson Manual of Medical Oncology. New York: Mcgraw-Hill, 2006.
24. Petrig C, Bassetti S, Passweg J, et al. Acute respiratory failure due to sweet syndrome. Am J Med Sci 2006; 331: 159-161.
25. Norhaya MR, Cheong SK, Hamidah NH, et al. Sweet-like syndrome in a patient with acute myeloid leukaemia. Singapore Med J 1996; 37: 320-322.
26. Yokoyama K, Kojima M, Komatsumoto S, et al. [Acute megakaryoblastic leukemia associated with Sweet's syndrome, including review of the literature]. Rinsho Ketsueki 1993; 34: 341-347.
27. Melinkeri SR, Gupta RK, Dabadghao S. A Sweet-like syndrome manifesting as gingival hyperplasia and myositis without cutaneous involvement. Ann Hematol 2002; 81: 397-398.
28. Callen JP. Acute febrile neutrophilic dermatosis (Sweet's syndrome) and the related conditions of 'bowel bypass'syndrome and bullous pyoderma gangrenosum. Dermatol Clin 1985; 3: 153-163.
29. Levine R, Wadleigh M, Cools J. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 2005; 7: 387-397.
30. Kravolics R, Passamonti F, Buser A. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 2005; 352: 1779-1790.
31. Baxter E, Scott L, Campbell P. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005; 365: 1054-1061.
32. Ayirookuzhi SJ, Ma L, Ramshesh P, et al. Imatinib-induced sweet syndrome in a patient with chronic myeloid leukemia. Arch Dermatol 2005; 141: 368-370.
33. Levy RM, Junkins-Hopkins JM, Turchi JJ, et al. Sweet syndrome as the presenting symptom of relapsed hairy cell leukemia. Arch Dermatol 2002; 138: 1551-1554.
34. Bayer-Garner IB, Cottler-Fox M, Smoller BR. Sweet syndrome in multiple myeloma: A series of six cases. J Cutan Pathol 2003; 30: 261-264.
35. Lichtman M, Beutler E, Kipps T, et al. Williams Hematology, 7th edn. New York: Mcgraw-Hill, 2006. Chapter 86.
36. McDermott MB, Corbally MT, O'Marcaigh AS. Extracutaneous Sweet syndrome involving the gastrointestinal tract in a patient with Fanconi anemia. J Pediatr Hematol Oncol 2001; 23: 59-62.
37. Vignon-Pennamen MD, Juillard C, Rybojad M, et al. Chronic recurrent lymphocytic Sweet syndrome as a predictive marker of myelodysplasia: A report of 9 cases. Arch Dermatol 2006; 142: 1170-1176.
38. Ohga S, Nomura A, Takada H, et al. Expansion of trisomy 8 and Sweet syndrome in a prolonged course of aplastic anemia. J Pediatr Hematol Oncol 2002; 24: 64-68.
39. Nischal KC, Khopkar U. An approach to the diagnosis of neutrophilic dermatoses: A histopathological perspective. Indian J Dermatol Venereol Leprol 2007; 73: 222-230.
40. Ratzinger G, Burgdorf W, Zelger BG, et al. Acute febrile neutrophilic dermatosis: A histopathologic study of 31 cases with review of literature. Am J Dermatopathol 2007; 29: 125-133.
41. Cohen PR. Skin lesions of Sweet syndrome and its dorsal hand variant contain vasculitis: An oxymoron or an epiphenomenon? Arch Dermatol 2002; 138: 400-403.
42. Cohen PR. Subcutaneous Sweet's syndrome: A variant of acute febrile neutrophilic dermatosis that is included in the histopathologic differential diagnosis of neutrophilic panniculitis. J Am Acad Dermatol 2005; 52: 927-928.
43. Cohen PR. Neutrophilic dermatoses occurring in oncology patients. Int J Dermatol 2007; 46: 106-111.
44. Yiannias JA, el-Azhary RA, Gibson LE. Erythema elevatum diutinum: A clinical and histopathologic study of 13 patients. J Am Acad Dermatol 1992; 26: 38-44.
45. Wilkinson SM, English JS, Smith NP, et al. Erythema elevatum diutinum: A clinicopathological study. Clin Exp Dermatol 1992; 17: 87-93.
46. Torok L, Kirschner A, Gurzo M, et al. Bullous pyoderma gangrenosum as a manifestation of leukemia cutis. Eur J Dermatol 2000; 10: 463-465.
47. Tassies D, Cervantes F, Feliu E, et al. [Behcet's disease with an onset prior to the appearance of chronic myeloid leukemia]. Med Clin (Barc) 1992; 99: 67-68.
48. Birnkrant MJ, Papadopoulos AJ, Schwartz RA, et al. Pyoderma gangrenosum, acne conglobata, and IgA gammopathy. Int J Dermatol 2003; 42: 213-216.
49. Cohen PR. Sweet's syndrome - a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis 2007; 2: 34.
50. Franzke A. The role of G-CSF in adaptive immunity. Cytokine Growth Factor Rev 2006; 17: 235-244.
51. Jagdeo J, Campbell R, Long T, et al. Sweet's syndrome - like neutrophilic lobular panniculitis associated with all-trans-retinoic acid chemotherapy in a patient with acute promyelocytic leukemia. J Am Acad Dermatol 2007; 56: 690-693.
52. Liu D, Seiter K, Mathews T, et al. Sweet's syndrome with CML cell infiltration of the skin in a patient with chronic-phase CML while taking Imatinib Mesylate. Leuk Res 2004; 28 (Suppl. 1): S61-S63.
53. Van Regenmortel N, Van de Voorde K, De Raeve H, et al. Bortezomib-induced Sweet's syndrome. Haematologica 2005; 90: ECR43.
54. Al-Saad K, Khanani MF, Naqvi A, et al. Sweet syndrome developing during treatment with all-trans retinoic acid in a child with acute myelogenous leukemia. J Pediatr Hematol Oncol 2004; 26: 197-199.
55. Bourke J, Keohane S, Long C, et al. Sweet's syndrome and malignancy in the U.K. Br J Dermatol 1997; 137 (4): 609-613.
56. Cohen PR, Kurzrock R. Chronic myelogenous leukemia and Sweet syndrome. Am J Hematol 1989; 32: 134-137.
57. Cohen PR, Almeida L, Kurzrock R. Acute febrile neutrophilic dermatosis. Am Fam Physician 1989; 39: 199-204.
58. Case JD, Smith SZ, Callen JP. The use of pulse methylprednisolone and chlorambucil in the treatment of Sweet's syndrome. Cutis 1989; 44: 125-129.
59. Sharma PK, Schwartz RA, Janniger CK, et al. Sweet's syndrome with acute leukemia. Cutis 1991; 47: 249-252.
60. Honma K, Saga K, Onodera H, et al. Potassium iodide inhibits neutrophil chemotaxis. Acta Derm Venereol 1990; 70: 247-249.
61. Suehisa S, Tagami H, Inoue F, et al. Colchicine in the treatment of acute febrile neutrophilic dermatosis (Sweet's syndrome). Br J Dermatol 1983; 108: 99-101.
62. Miyachi Y, Niwa Y. Effects of potassium iodide, colchicine and dapsone on the generation of polymorphonuclear leukocyte-derived oxygen intermediates. Br J Dermatol 1982; 107: 209-214.
63. Suehisa S, Tagami H. Treatment of acute febrile neutrophilic dermatosis (Sweet's syndrome) with colchicine. Br J Dermatol 1981; 105: 483.
64. Horio T, Imamura S, Danno K, et al. Treatment of acute febrile neutrophilic dermatosis (Sweet's Syndrome) with potassium iodide. Dermatologica 1980; 160: 341-347.
65. Altomare G, Capella GL, Frigerio E. Sweet's syndrome in a patient with idiopathic myelofibrosis and thymoma-myasthenia gravis-immunodeficiency complex: Efficacy of treatment with etretinate. Haematologica 1996; 81: 54-58.
66. Sharpe GR, Leggat HM. A case of Sweet's syndrome and myelodysplasia: response to cyclosporin. Br J Dermatol 1992; 127: 538-539.
67. Cather JC, Abramovits W, Menter A. Cyclosporine and tacrolimus in dermatology. Dermatol Clin 2001; 19: 119-137, ix.
68. Fitzgerald RL, McBurney EI, Nesbitt LT Jr. Sweet's syndrome. Int J Dermatol 1996; 35: 9-15.
69. von den Driesch P, Steffan C, Zobe A, et al. Sweet's syndrome - therapy with cyclosporin. Clin Exp Dermatol 1994; 19: 274-277.
70. Physician's Desk Reference. In: Thomson, 2007.
71. Brodkin RH, Schwartz RA. Sweet's syndrome with myelofibrosis and leukemia: Partial response to interferon. Dermatology 1995; 190: 160-163.
72. Sacchi S, Kantarjian H, O'Brien S, et al. Immune-mediated and unusual complications during interferon α therapy in chronic myelogenous leukemia. J Clin Oncol 1995; 13: 2401-2407.
73. Colovic M, Jankovic G, Suvajdzic N, et al. Structural chromosomal abnormality of 1q in acute leukemia with Sweet syndrome. Cancer Genet Cytogenet 2002; 139: 84-85.
74. Salmon-Ehr V, Esteve E, Serpier H, et al. [Acute febrile pustular and bullous neutrophilic dermatosis (Sweet syndrome) disclosing acute myeloblastic leukemia]. Rev Med Interne 1995; 16: 347-350.
75. Dompmartin A, Troussard X, Lorier E, et al. Sweet syndrome associated with acute myelogenous leukemia. Atypical form simulating facial erysipelas. Int J Dermatol 1991; 30: 644-647.
76. Pirard C, Delannoy A. [Sweet syndrome and acute myeloid leukemia]. Ann Dermatol Venereol 1977; 104: 160-161.
77. Fain O, Mathieu E, Feton N, et al. Intestinal involvement in Sweet's syndrome. J Am Acad Dermatol 1996; 35: 989-990.
78. Raimer S, Duncan W. Febrile neutrophilic dermatosis in acute myelogenous leukemia. Arch Dermatol 1978; 114: 413-414.
79. Klock J, Oken R. Febrile neutrophilic dermatosis in acute myelogenous leukemia. Cancer 1976; 37: 922-927.
80. Piette W, Trapp J, O'Donnel M, et al. Acute neutrophilic dermatosis with myeloblastic infiltrate in a leukemic patient receiving all-trans-retinoic therapy. J Am Acad Dermatol 1994; 30: 293-297.
81. Cox N, O'Brien H. Sweet's syndrome associated with transretinoic acid treatment in acute promyelocytic leukaemia. Clin Exp Dermatol 1994; 19: 51-52.
82. Kannan R, Dutta TK, Goel A, et al. Sweet syndrome in chronic myeloid leukaemia. Postgrad Med J 1995: 71: 383.
83. Shimamoto Y, Narisawa Y, Suga K, et al. Relationship between autoantibody and dermatosis in myelodysplastic syndrome. Haematologia (Budap) 1993; 25: 253-261.
84. Gonzalez-Castro U, Julia A, Pedragosa R, et al. Sweet syndrome in chronic myelogenous leukemia. Int J Dermatol 1991; 30: 648-650.
85. Rauh G, Gresser U, Meurer M, et al. [Sweet syndrome in chronic myeloid leukemia]. Klin Wochenschr 1989; 67: 506-510.
86. Odeh F. [Sweet syndrome in systemic diseases (authors transl)]. Z Hautkr 1981; 56: 1081-1088.
87. Urano Y, Miyaoka Y, Kosaka M, et al. Sweet's syndrome associated with chronic myelogenous leukemia: Demonstration of leukemic cells within a skin lesion. J Am Acad Dermatol 1999; 40: 275-279.
88. del Pozo J, Martinez W, Pazos JM, et al. Concurrent Sweet's syndrome and leukemia cutis in patients with myeloid disorders. Int J Dermatol 2005; 44: 677-680.
89. Harada Y, Egi Y, Honda Y, et al. [Multiple myeloma with Sweet disease developing from monoclonal gammopathy of undetermined significance and Sjogren syndrome]. Rinsho Ketsueki 2001; 42: 1176-1180.
90. Colovic MD, Jankovic GM, Novak AZ, et al. Sweet's syndrome associated with paracentric inversion of chromosome 3q in a patient with multiple myeloma. European J Haematol 1996; 57: 188-189.
91. Gisser SD. Acute febrile neutrophilic dermatosis (Sweet's syndrome) in a patient with hairy-cell leukemia. Am J Dermatopathol 1983; 5: 283-288.
92. Glaspy JA, Baldwin GC, Robertson PA, et al. Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony-stimulating factor. Ann Intern Med 1988; 109: 789-795.
93. Dalri P, Boi S, Cristofolini M, Piscioli F, et al. Sweet syndrome: presenting symptom of hairy cell leukemia with fatal infection by pneumocystis carinii. Haematologica 1982; 67: 765-768.
94. Chang SS, Chau WK, Liu MT, et al. Acute febrile neutrophilic dermatosis (Sweet's syndrome) in hairy cell leukemia: A case report. Zhonghua Yi Xue Za Zhi (Taipei) 1999; 62: 467-471.
95. Kramers C, Raemaekers JM, van Baar HM, et al. Sweet's syndrome as the presenting symptom of hairy cell leukemia with concomitant infection by Mycobacterium kansasii. Ann Hematol 1992; 65: 55-58.
96. Karamlou K, Gorn AH. Refractory sweet syndrome with autoimmune organizing pneumonia treated with monoclonal antibodies to tumor necrosis factor. J Clin Rheumatol 2004; 10: 331-335.
97. Tomasini C, Aloi F, Osella-Abate S, Dapavo P, et al. Immature myeloid precursors in chronic neutrophilic dermatosis associated with myelodysplastic syndrome. Am J Dermatopathol 2000; 22: 429-433.
98. Shimizu T, Yoshida I, Eguchi H, et al. Sweet syndrome in a child with aplastic anemia receiving recombinant granulocyte colony-stimulating factor. J Pediatr Hematol Oncol 1996; 18: 282-284.
99. Grune S, Panizzon R, Egli F, et al. [The appearance of Sweet's syndrome during the transition from a myelodysplastic syndrome to erythroleukemia]. Dtsch Med Wochenschr 1996; 121: 939-942.
100. Baron F, Sybert VP, Andrews RG. Cutaneous and extracutaneous neutrophilic infiltrates (Sweet syndrome) in three patients with Fanconi anemia. J Pediatr 1989; 115: 726-729.
101. Soppi E, Nousiainen T, Seppa A, et al. Acute febrile neutrophilic dermatosis (Sweet's syndrome) in association with myelodysplastic syndromes: A report of three cases and a review of the literature. Br J Haematol 1989; 73: 43-47.